The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancer
- 20 August 2008
- journal article
- Published by Wiley in BJU International
- Vol. 102 (6) , 756-761
Abstract
OBJECTIVE: To examine the relationship between the systemic inflammatory response (C‐reactive protein, CRP), tumour interleukin‐6 receptor and cyclooxygenase (COX)‐2 expression, tumour T‐lymphocytic (CD4+, CD8+) infiltration and cancer survival in patients undergoing resection for renal cell carcinoma (RCC), as both the local and systemic inflammatory responses appear to predict the outcome in these patients. PATIENTS AND METHODS: The study included 60 patients undergoing nephrectomy for localized RCC. Pre‐operative circulating CRP levels were measured and tumour interleukin‐6 receptor and COX‐2 expression, tumour CD4+ and CD8+ T lymphocytes were assessed using immunohistochemical analysis. RESULTS: The median follow‐up was 78 months, with 14 patients relapsing from their disease and nine cancer‐specific deaths. On univariate and multivariate survival analysis, tumour stage and grade and CRP levels were identified as significant factors associated with relapse‐free and cancer‐specific survival. There was a significant direct relationship between Fuhrman grade and CD4+ T‐lymphocytic infiltrate ( P < 0.05). An increase in tumour expression of interleukin‐6 receptor was weakly associated with an increase in tumour CD8+ T‐lymphocytic infiltration ( P = 0.057). An increase in tumour CD4+ T‐lymphocytic infiltration was associated with an increase in CD8+ T‐lymphocytic infiltration ( P < 0.01). CONCLUSIONS: The present results suggest that tumour‐based factors such as interleukin‐6 receptor and COX‐2 expression or T‐lymphocytic subset infiltration are subordinate to systemic factors such as CRP level in determining survival in patients with localized RCC.Keywords
This publication has 45 references indexed in Scilit:
- Evaluation of an inflammation‐based prognostic score in patients with metastatic renal cancerCancer, 2007
- Interleukin 6: from bench to bedsideNature Clinical Practice Rheumatology, 2006
- An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancerBritish Journal of Cancer, 2006
- Cyclooxygenase-2 and p53 Expression as Prognostic Indicators in Conventional Renal Cell CarcinomaYonsei Medical Journal, 2005
- Inflammation and necrosis promote tumour growthNature Reviews Immunology, 2004
- Significant Host- and Tumor-Related Factors for Predicting Prognosis in Patients With Esophageal CarcinomaAnnals of Surgery, 2003
- COX-2, Inflammatory Secreted PLA2, and Cytoplasmic PLA2 Protein Expression in Small Bowel Adenocarcinomas Compared with Colorectal AdenocarcinomasLaboratory Investigation, 2003
- Inflammation and cancerNature, 2002
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999
- Effect of extended ibuprofen administration on the acute phase protein response in colorectal cancer patientsEuropean Journal of Surgical Oncology, 1995